BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1046 related articles for article (PubMed ID: 26322599)

  • 1. Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium.
    Suresh SC; Selvaraju V; Thirunavukkarasu M; Goldman JW; Husain A; Alexander Palesty J; Sanchez JA; McFadden DW; Maulik N
    Int J Cardiol; 2015 Dec; 201():517-28. PubMed ID: 26322599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thioredoxin-1 gene therapy enhances angiogenic signaling and reduces ventricular remodeling in infarcted myocardium of diabetic rats.
    Samuel SM; Thirunavukkarasu M; Penumathsa SV; Koneru S; Zhan L; Maulik G; Sudhakaran PR; Maulik N
    Circulation; 2010 Mar; 121(10):1244-55. PubMed ID: 20194885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats.
    Tang J; Wang J; Yang J; Kong X; Zheng F; Guo L; Zhang L; Huang Y
    Eur J Cardiothorac Surg; 2009 Oct; 36(4):644-50. PubMed ID: 19524448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment of mesenchymal stem cells with angiotensin II enhances paracrine effects, angiogenesis, gap junction formation and therapeutic efficacy for myocardial infarction.
    Liu C; Fan Y; Zhou L; Zhu HY; Song YC; Hu L; Wang Y; Li QP
    Int J Cardiol; 2015 Jun; 188():22-32. PubMed ID: 25880576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MSCs transfected with hepatocyte growth factor or vascular endothelial growth factor improve cardiac function in the infarcted porcine heart by increasing angiogenesis and reducing fibrosis.
    Lu F; Zhao X; Wu J; Cui Y; Mao Y; Chen K; Yuan Y; Gong D; Xu Z; Huang S
    Int J Cardiol; 2013 Sep; 167(6):2524-32. PubMed ID: 22981278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of myocardial transplantation of mesenchymal stem cells transfected with vascular endothelial factor gene on improvement of heart function and angiogenesis after myocardial infarction: experiment with rats].
    Yang JF; Zhou WW; Tang T; Yu JF; Zhou XM; Hu JG
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(15):1027-34. PubMed ID: 16784704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion.
    Tang J; Xie Q; Pan G; Wang J; Wang M
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):353-61. PubMed ID: 16829080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction.
    Yang J; Zhou W; Zheng W; Ma Y; Lin L; Tang T; Liu J; Yu J; Zhou X; Hu J
    Cardiology; 2007; 107(1):17-29. PubMed ID: 16741354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survival.
    Huang F; Zhu X; Hu XQ; Fang ZF; Tang L; Lu XL; Zhou SH
    Int J Mol Med; 2013 Feb; 31(2):484-92. PubMed ID: 23229021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of chemokine and angiogenic factor genes and mesenchymal stem cells could enhance angiogenesis and improve cardiac function after acute myocardial infarction in rats.
    Tang J; Wang J; Zheng F; Kong X; Guo L; Yang J; Zhang L; Huang Y
    Mol Cell Biochem; 2010 Jun; 339(1-2):107-18. PubMed ID: 20058054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell transplantation into ischemic myocardium using mesenchymal stem cells transfected by vascular endothelial growth factor.
    Hua P; Tao J; Liu JY; Yang SR
    Int J Clin Exp Pathol; 2014; 7(11):7782-8. PubMed ID: 25550816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium.
    Pasha Z; Wang Y; Sheikh R; Zhang D; Zhao T; Ashraf M
    Cardiovasc Res; 2008 Jan; 77(1):134-42. PubMed ID: 18006467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Over-expression of CXCR4 on mesenchymal stem cells augments myoangiogenesis in the infarcted myocardium.
    Zhang D; Fan GC; Zhou X; Zhao T; Pasha Z; Xu M; Zhu Y; Ashraf M; Wang Y
    J Mol Cell Cardiol; 2008 Feb; 44(2):281-92. PubMed ID: 18201717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance.
    Cheng Z; Ou L; Zhou X; Li F; Jia X; Zhang Y; Liu X; Li Y; Ward CA; Melo LG; Kong D
    Mol Ther; 2008 Mar; 16(3):571-9. PubMed ID: 18253156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol enhances neovascularization in the infarcted rat myocardium through the induction of thioredoxin-1, heme oxygenase-1 and vascular endothelial growth factor.
    Kaga S; Zhan L; Matsumoto M; Maulik N
    J Mol Cell Cardiol; 2005 Nov; 39(5):813-22. PubMed ID: 16198371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic induction of pro-angiogenic milieu after transplantation of marrow-derived mesenchymal stem cells in experimental myocardial infarction.
    Rahbarghazi R; Nassiri SM; Ahmadi SH; Mohammadi E; Rabbani S; Araghi A; Hosseinkhani H
    Int J Cardiol; 2014 May; 173(3):453-66. PubMed ID: 24679689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of combined mesenchymal stem cells and heme oxygenase-1 therapy on cardiac performance.
    Zeng B; Chen H; Zhu C; Ren X; Lin G; Cao F
    Eur J Cardiothorac Surg; 2008 Oct; 34(4):850-6. PubMed ID: 18640847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A promising strategy for the treatment of ischemic heart disease: Mesenchymal stem cell-mediated vascular endothelial growth factor gene transfer in rats.
    Gao F; He T; Wang H; Yu S; Yi D; Liu W; Cai Z
    Can J Cardiol; 2007 Sep; 23(11):891-8. PubMed ID: 17876381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-Kit Positive Cardiac Stem Cells and Bone Marrow-Derived Mesenchymal Stem Cells Synergistically Enhance Angiogenesis and Improve Cardiac Function After Myocardial Infarction in a Paracrine Manner.
    Bao L; Meng Q; Li Y; Deng S; Yu Z; Liu Z; Zhang L; Fan H
    J Card Fail; 2017 May; 23(5):403-415. PubMed ID: 28284757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suicide gene reveals the myocardial neovascularization role of mesenchymal stem cells overexpressing CXCR4 (MSC(CXCR4)).
    Liang J; Huang W; Yu X; Ashraf A; Wary KK; Xu M; Millard RW; Ashraf M; Wang Y
    PLoS One; 2012; 7(9):e46158. PubMed ID: 23029422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.